InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
80.41
(
-0.21%
)
Bitcoin
69,416.19
(
1.67%
)
Post# of 114752
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

valuemind

Send PM Follow Ignore
Followers 40
Posts 1641
Boards Moderated 0
Alias Born 01/21/2005

valuemind

Re: wadegarret post# 108307

Monday, 11/06/2023 1:30:56 PM

Monday, November 06, 2023 1:30:56 PM

Post# of 114752
GERN: In case imetelstat indeed gets FDA approved in June 2024, the company need spend tons of money in marketing and selling. CEO said the market potential for imetelstat type of drugs is $3.5 billion. If imetelstat gets 10% market share, it will have about $350 million revenue a year, compared to its current market capitalization over $1 billion. Seems it is fairly valued. Do I miss something?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up